Bader Zarrouki
Biopharmaceuticals R&D
Goeteborg, O 43183, Sweden
Goeteborg, O 43183, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Systematic Application of a Cellular Thermal Shift Assay for Inferring Inhibitor Binding Affinity to 17βHSD13 in a Humanized Liver Homogenate.
Journal: Biochemistry
Published: January 12, 2026
Density-adjusted analysis of cell interactions to decipher tissue landscape changes.
Journal: iScience
Published: May 07, 2025
Thermoneutrality accelerates a distinctive metabolic dysfunction-associated steatohepatitis phenotype in a diet-induced male mouse model with similarities to human disease.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 22, 2024
DECORIN, a triceps-derived myokine, protects sorted β-cells and human islets against chronic inflammation associated with type 2 diabetes.
Journal: Acta physiologica (Oxford, England)
Published: September 05, 2024
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes.
Journal: Science advances
Published: November 16, 2022
Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats.
Journal: Science translational medicine
Published: October 26, 2022
Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis.
Journal: Aging
Published: August 30, 2022
Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation.
Journal: ACS medicinal chemistry letters
Published: December 22, 2021
An Obesogenic Dietary Mouse Model of Nonalcoholic Steatohepatitis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 02, 2020
Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats.
Journal: Diabetologia
Published: August 04, 2016
Last Updated: 09/26/2026